New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

by Katie Marquedant,Massachusetts General HospitalDistribution of recurrent melanomas in the study population. Among the 310 recurrent melanomas, 255 (82%) recurred within five years and 285 (92
Oncology January 02,2024
Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

by Katie Marquedant,Massachusetts General HospitalDistribution of recurrent melanomas in the study population. Among the 310 recurrent melanomas, 255 (82%) recurred within five years and 285 (92
Oncology January 02,2024
Making melanoma immortal: Scientists discover key genetic step in cancer's race to live forever

Making melanoma immortal: Scientists discover key genetic step in cancer's race to live forever

byUniversity of PittsburghHuman chromosomes (gray) capped by telomeres (white). Credit: PD-NASA; PD-USGOV-NASAScientists at the University of Pittsburgh School of Medicine have discovered the mi
Oncology January 02,2024
Making melanoma immortal: Scientists discover key genetic step in cancer's race to live forever

Making melanoma immortal: Scientists discover key genetic step in cancer's race to live forever

byUniversity of PittsburghHuman chromosomes (gray) capped by telomeres (white). Credit: PD-NASA; PD-USGOV-NASAScientists at the University of Pittsburgh School of Medicine have discovered the mi
Oncology January 02,2024
Cardiologist explains how pacemakers and defibrillators interact with the electrical system of the heart

Cardiologist explains how pacemakers and defibrillators interact with the electrical system of the heart

by Virginia Singla,The ConversationBreakdowns in the sinoatrial and atrioventricular nodes can cause heart rate problems. Credit:Rob Kreuger, medical illustrator/Wikimedia Commons,CC
Cardiovascular Diseases January 02,2024
Cardiologist explains how pacemakers and defibrillators interact with the electrical system of the heart

Cardiologist explains how pacemakers and defibrillators interact with the electrical system of the heart

by Virginia Singla,The ConversationBreakdowns in the sinoatrial and atrioventricular nodes can cause heart rate problems. Credit:Rob Kreuger, medical illustrator/Wikimedia Commons,CC
Cardiovascular Diseases January 02,2024
Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre
Oncology January 02,2024
Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre
Oncology January 02,2024
Why children should not ride e-scooters

Why children should not ride e-scooters

by Ashley Ebersole, MD, MS, FAAP, American Academy of PediatricsCredit: Pixabay/CC0 Public DomainShared or personal use electric scooters (e-scooters) are common in cities and on college campuses acro
Pediatrics January 02,2024
Why children should not ride e-scooters

Why children should not ride e-scooters

by Ashley Ebersole, MD, MS, FAAP, American Academy of PediatricsCredit: Pixabay/CC0 Public DomainShared or personal use electric scooters (e-scooters) are common in cities and on college campuses acro
Pediatrics January 02,2024
Multi-site study reveals addressable socioeconomic barriers to prenatal diagnosis of congenital heart defects

Multi-site study reveals addressable socioeconomic barriers to prenatal diagnosis of congenital heart defects

byAnn & Robert H. Lurie Children's Hospital of ChicagoCredit: CC0 Public DomainPrenatal diagnosis of congenital heart defects—the most common birth defects in the United States—is associ
OB & GYN January 02,2024
Multi-site study reveals addressable socioeconomic barriers to prenatal diagnosis of congenital heart defects

Multi-site study reveals addressable socioeconomic barriers to prenatal diagnosis of congenital heart defects

byAnn & Robert H. Lurie Children's Hospital of ChicagoCredit: CC0 Public DomainPrenatal diagnosis of congenital heart defects—the most common birth defects in the United States—is associ
OB & GYN January 02,2024
Researchers develop material that reduces bacterial infection and speeds up bone healing

Researchers develop material that reduces bacterial infection and speeds up bone healing

by Laura Anderson,Royal College of Surgeons in IrelandAntagomiR-138-activated scaffolds were well integrated within the bone defect. The H&E staining showed remarkable cellular infiltration
Orthopedics & Sports medicine January 02,2024
Researchers develop material that reduces bacterial infection and speeds up bone healing

Researchers develop material that reduces bacterial infection and speeds up bone healing

by Laura Anderson,Royal College of Surgeons in IrelandAntagomiR-138-activated scaffolds were well integrated within the bone defect. The H&E staining showed remarkable cellular infiltration
Orthopedics & Sports medicine January 02,2024
A shape-shifting robotic catheter could make heart surgery safer

A shape-shifting robotic catheter could make heart surgery safer

by National Institute of Biomedical Imaging and BioengineeringClinical workflow for the demonstrated device applications.(A) The device moves toward the right atrium through the superior vena cava via
Cardiovascular Diseases January 02,2024
A shape-shifting robotic catheter could make heart surgery safer

A shape-shifting robotic catheter could make heart surgery safer

by National Institute of Biomedical Imaging and BioengineeringClinical workflow for the demonstrated device applications.(A) The device moves toward the right atrium through the superior vena cava via
Cardiovascular Diseases January 02,2024
Stem cell therapy shows promise for treating multiple sclerosis—new study

Stem cell therapy shows promise for treating multiple sclerosis—new study

by Luca Peruzzotti-Jametti and Stefano Pluchino,The ConversationCredit: CC0 Public DomainOver 2 million people globally havemultiple sclerosis (MS), a disease that affects the nervous syst
Neurology January 02,2024
Stem cell therapy shows promise for treating multiple sclerosis—new study

Stem cell therapy shows promise for treating multiple sclerosis—new study

by Luca Peruzzotti-Jametti and Stefano Pluchino,The ConversationCredit: CC0 Public DomainOver 2 million people globally havemultiple sclerosis (MS), a disease that affects the nervous syst
Neurology January 02,2024
Research reveals novel ways of cultivating brain cells to treat and study

Research reveals novel ways of cultivating brain cells to treat and study

byDuke-NUS Medical SchoolSurvival of grafted NPCs in the ischemic core. Credit:Advanced Science(2023). DOI: 10.1002/advs.202302527Scientists from Duke-NUS Medical School and their co
Neurology January 02,2024
Research reveals novel ways of cultivating brain cells to treat and study

Research reveals novel ways of cultivating brain cells to treat and study

byDuke-NUS Medical SchoolSurvival of grafted NPCs in the ischemic core. Credit:Advanced Science(2023). DOI: 10.1002/advs.202302527Scientists from Duke-NUS Medical School and their co
Neurology January 02,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com